TVRD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Tvardi Therapeutics Inc (TVRD) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock lacks significant positive catalysts, has weak financial performance, and shows no clear technical or trading signals. While analysts see potential upside with a $6 price target, the current technical and financial conditions do not support immediate action.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 33.934, and moving averages (SMA_200 > SMA_20 > SMA_5) indicate a bearish trend. The stock is trading below its pivot level of 3.918, with support at 3.559 and resistance at 4.277.
Lucid Capital upgraded the stock to Buy with a $6 price target, citing undervaluation and potential for key readouts in 2026.
No recent news or significant insider/hedge fund trading activity. Financial performance is weak with negative net income and EPS. Technical indicators are bearish, and there is no recent congress trading data.
In Q3 2025, the company reported zero revenue growth, a net income of -$5.53M (up 0.25% YoY), and a significant drop in EPS (-72.43% YoY). Gross margin remains at 0%.
Lucid Capital upgraded the stock to Buy from Neutral with a $6 price target, citing undervaluation and the potential for its assets to drive growth.
